UNITAID s approach to funding innovations in TB diagnosis and treatment Robert Matiru & Janet Ginnard, UNITAID Geneva, 29 April 2015

Size: px
Start display at page:

Download "UNITAID s approach to funding innovations in TB diagnosis and treatment Robert Matiru & Janet Ginnard, UNITAID Geneva, 29 April 2015"

Transcription

1 UNITAID UNITAID s approach to funding innovations in TB diagnosis and treatment Robert Matiru & Janet Ginnard, UNITAID Geneva, 29 April 2015

2 Page 2 UNITAID's role in the global response By connecting the upstream to the downstream and enabling others to do more with less

3 Page 3 UNITAID strategy & market impact approach

4 Strategic framework: UNITAID's contribution to the global response maps to global goals and challenges Disease Global Goals Challenges Opportunities UTD projects & results HIV TB What are targets the world agrees on? What are the needs, gaps, limitations? Where can UNITAID play a catalytic, enabling role? How does each project fit? Malaria Landscapes + engagement & alignment with partners Solicitation of ideas, development of grants, alignment with partners What are the objectives, impact and value for money? 4

5 Strategic framework: UNITAID work in TB diagnostics Global Goals Challenges Opportunities UTD projects & results 90% reduction in new cases 95% reduction in deaths Underdiagnosis; need for inexpensive POC tests Poor access to drug susceptibility testing; evolving testing needs Foster competitive market to improve diagnostic speed and access Improve access to appropriate drug susceptibility testing EXPAND TB WHO Global TB programme / FIND / Stop TB Partnership / GDF Expanded access to quality TB diagnostics: 3 new technologies scaled up >106,000 MDR-TB cases detected No catastrophic costs due to TB Diagnostics not adapted for specific patient groups (e.g., children) Encourage better diagnostics for underserved patient groups TBXpert WHO Global TB programme / Stop TB Partnership / Cepheid Reduced price Scaled up Xpert MTB/RIF: >1.4 m cartridges in 21 countries 5

6 Strategic framework: UNITAID work in TB medicines Global Goals Challenges Opportunities UTD projects & results 90% reduction in new cases 95% reduction in deaths No catastrophic costs due to TB Medicines not adapted for children Long, complex, toxic, expensive MDR-TB regimens Limited experience with new MDR-TB drugs Small, fragmented markets, especially for MDR TB: Many untreated cases Poor visibility on demand Many treatment options, many variations of each Develop better paediatric medicines (new formulations) Inform use of new medicines & regimens: Speed access Improve outcomes Focus market on better, shorter, less toxic regimens Stabilize / sustain TB medicines markets with targeted interventions Paediatric TB drugs GDF Improved uptake in 58 countries STEP TB TB Alliance/WHO New paediatric FDCs endtb PIH, MSF, IRD Accelerate access Develop shorter, less toxic, novel regimens MDR-TB Strategic Rotating Stockpile GDF Stabilize supply: reduce stock-outs and lead times 6

7 An integrated approach to diagnosis and treatment Market scoping & consultations Market intelligence Landscape reports Dashboard Expert consultation with stakeholders 7 Page 7 Source: UNITAID Market Dynamics Dashboard, April 2015

8 Informed by an understanding of the technology landscape TB diagnostics pipeline (Dec 2014) Source: UNITAID 2014 Tuberculosis Diagnostics Technology and Market Landscape 8

9 And review of market challenges & opportunities Donor-funded medicines purchases by product formulation, 2012 ($m) HIV/AIDS (total $858M) Malaria (total $189M) TB (total $66M) 9 Page 9 Source: Analysis of market & partner data; see: UNITAID 2014 Tuberculosis Medicines Technology and Market Landscape

10 Page 10 Looking ahead: what s next in TB diagnostics & medicines? TB diagnostics TB diagnostics Define market opportunity and accelerate market entry for innovative TB diagnostics that address unmet needs Alignment with identified priorities More diversified market Testing closer to point of care Diagnostics to support access to new medicines/regimens May include support for demonstration of performance and/or scale-up TB medicines TB medicines Support responsible introduction of new medicines Accelerate access to new drugs: shift the uptake curve for early and sustained access Special consideration for new TB medicines: need for further evidence + support for introduction in countries (e.g., pharmacovigilance) Develop shorter, more effective regimens

11 Page 11 Fostering continued innovation in TB diagnostics: Xpert and beyond Current molecular diagnostics Complement Xpert & encourage a more competitive market: Diagnose more patients, faster Future Product selection illustrative only Address gaps: Diagnose closer to point of care Anticipate new diagnostic needs (DST): companion diagnostics to enable broad access for new drug regimens Other supportive measures in parallel (non-product-specific): Connectivity: promote actionable, rapid results & reporting Linkage to care: full DST after rapid testing, if needed; initiation on appropriate treatment External quality assurance

12 Page 12 Innovation in MDR-TB medicines: endtb PIH, MSF & IRD project supporting access to new TB drugs Goal: Increase uptake of new TB drugs in regimens that are better, shorter, and less toxic Activity # Patients Outcome Impact Cohort 2600 treated Experience with new MDR-TB drugs (safety and efficacy) Evidence to inform WHO guidance Increase access to new medicines (short-term) Trial 600 enrolled Priority MDR-TB regimens that are shorter (< 1 year) and less toxic (no injectable) Evidence to inform WHO guidance Simplify regimens (long-term) Simpler regimens will enable further access gains: Fewer medicines needed for an effective regimen Harmonize and optimize treatment (donors, countries, private sector) Consolidation in quality assurance Focused market allowing more efficient production, supply chain, etc.

13 Thank you!

EXECUTIVE BOARD MEETING METHODOLOGY FOR DEVELOPING STRATEGIC NARRATIVES

EXECUTIVE BOARD MEETING METHODOLOGY FOR DEVELOPING STRATEGIC NARRATIVES EXECUTIVE BOARD MEETING METHODOLOGY FOR DEVELOPING STRATEGIC NARRATIVES EXECUTIVE BOARD MEETING METHODOLOGY FOR DEVELOPING STRATEGIC NARRATIVES 1.Context and introduction 1.1. Context Unitaid has adopted

More information

UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview

UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview December 2009 UNITAID Mission UNITAID's Mission Scale up access to treatment for HIV/AIDS, malaria and TB Leverage price reductions of quality

More information

A Costed Framework for the Global Drug Resistant TB Initiative (GDI),

A Costed Framework for the Global Drug Resistant TB Initiative (GDI), A Costed Framework for the Global Drug Resistant TB Initiative (GDI), 2017-2018 Table of Contents A. Introduction... 3 B. Main activities and funding streams within the current MDR-TB space... 6 C. Stakeholder

More information

The case for quality

The case for quality The case for quality Around the world, up to two billion people lack access to quality essential medicines. Poor-quality medicines undermine the treatment of some of the world s most pressing diseases,

More information

Access to current products and innovation for the future- Some community Thoughts. Kenly Sikwese Geneva 1 November 2011

Access to current products and innovation for the future- Some community Thoughts. Kenly Sikwese Geneva 1 November 2011 Access to current products and innovation for the future- Some community Thoughts Kenly Sikwese Geneva 1 November 2011 Financing the response Current ART successes have been predicated on sustained new

More information

Draft Plan of Action Chair's Text Status 3 May 2008

Draft Plan of Action Chair's Text Status 3 May 2008 Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background

More information

MAXIMIZING THE HEALTH IMPACT OF DIAGNOSTIC SOLUTIONS ACCESS STRATEGY 2018

MAXIMIZING THE HEALTH IMPACT OF DIAGNOSTIC SOLUTIONS ACCESS STRATEGY 2018 MAXIMIZING THE HEALTH IMPACT OF DIAGNOSTIC SOLUTIONS ACCESS STRATEGY 2018 ABOUT FIND FIND was founded in 2003 to bridge existing development gaps for essential diagnostics by initiating and coordinating

More information

FDA Centers of Excellence in Regulatory and Information Sciences

FDA Centers of Excellence in Regulatory and Information Sciences FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in

More information

A comprehensive partner and activity mapping exercise

A comprehensive partner and activity mapping exercise Supply and access initiatives for internationally quality-assured second-line drugs against tuberculosis: A comprehensive partner and activity mapping exercise Assembled in 2017 in collaboration with And

More information

Horizon 2020 Towards a Common Strategic Framework for EU Research and Innovation Funding

Horizon 2020 Towards a Common Strategic Framework for EU Research and Innovation Funding Horizon 2020 Towards a Common Strategic Framework for EU Research and Innovation Funding Rudolf Strohmeier DG Research & Innovation The context: Europe 2020 strategy Objectives of smart, sustainable and

More information

70 th World Health Assembly May 2017 MSF Briefing on Medical Research and Development

70 th World Health Assembly May 2017 MSF Briefing on Medical Research and Development 70 th World Health Assembly May 2017 MSF Briefing on Medical Research and Development Overview Médecins Sans Frontières (MSF) welcomes the increased attention by WHO and Member States to find ways to ensure

More information

Elements of a global strategy and plan of action

Elements of a global strategy and plan of action INTERGOVERNMENTAL WORKING GROUP A/PHI/IGWG/1/5 ON PUBLIC HEALTH, INNOVATION AND 8 December 2006 INTELLECTUAL PROPERTY Agenda item 2.3 Elements of a global strategy and plan of action Progress to date in

More information

ABHI Response to the Kennedy short study on Valuing Innovation

ABHI Response to the Kennedy short study on Valuing Innovation ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.

More information

Overview on Medicines Regulation: regulatory cooperation and harmonization in focus

Overview on Medicines Regulation: regulatory cooperation and harmonization in focus Overview on Medicines Regulation: regulatory cooperation and harmonization in focus Dr Samvel Azatyan Manager, Medicines Regulatory Support Programme Quality Assurance and Safety: Medicines Essential Medicines

More information

ERDF Stakeholder Workshop 4 th May 2016: Overview and Priorities

ERDF Stakeholder Workshop 4 th May 2016: Overview and Priorities ERDF Stakeholder Workshop 4 th May 2016: Overview and Priorities Paul Witcombe Enterprise and Innovation Manager Hertfordshire LEP Email: paul.witcombe@hertfordshirelep.co.uk Tel: 07500 882000 STRUCTURE

More information

Off label use Bedaquilline beyond 24 weeks Lorenzo Guglielmetti Bligny Hospital, France

Off label use Bedaquilline beyond 24 weeks Lorenzo Guglielmetti Bligny Hospital, France Patients and TB: Improving treatment outcomes through a patient centred approach and access to new treatments 5 th TB Symposium Eastern Europe and Central Asia Ministry of Labour, Health and Social Affairs

More information

Health Innovations in Horizon 2020: the framework programme for research and innovation ( )

Health Innovations in Horizon 2020: the framework programme for research and innovation ( ) Health Innovations in Horizon 2020: the framework programme for research and innovation (2014-2020) Virginija Dambrauskaite, MD, PhD Scientific Officer, Medical Research Unit, Health Directorate Directorate-General

More information

Global strategy and plan of action on public health, innovation and intellectual property

Global strategy and plan of action on public health, innovation and intellectual property SIXTY-FIRST WORLD HEALTH ASSEMBLY WHA61.21 Agenda item 11.6 24 May 2008 Global strategy and plan of action on public health, innovation and intellectual property The Sixty-first World Health Assembly,

More information

Affordable Medicines Facility-malaria (AMFm): Innovative Financing for Better Access

Affordable Medicines Facility-malaria (AMFm): Innovative Financing for Better Access Affordable Medicines Facility-malaria (AMFm): Innovative Financing for Better Access Medicines For Malaria Venture Stakeholders Meeting, Dar-es-Salaam, 3 June 2011 Olusoji Adeyi, MD, DrPH, MBA Director

More information

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as: HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually

More information

Enabling ICT for. development

Enabling ICT for. development Enabling ICT for development Interview with Dr M-H Carolyn Nguyen, who explains why governments need to start thinking seriously about how to leverage ICT for their development goals, and why an appropriate

More information

Workshop on Enabling Technologies in CSF for EU Research and Innovation Funding

Workshop on Enabling Technologies in CSF for EU Research and Innovation Funding Workshop on Enabling Technologies in CSF for EU Research and Innovation Funding Rapporteur Professor Costas Kiparissides, Department of Chemical Engineering, Aristotle University of Thessaloniki Brussels,

More information

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing Jeremy Bray DG Research & Innovation European Commission National NHS day Leeds, UK, 29 January 2014 What is Horizon 2020? The

More information

Synergies and Complementarities with EU Research & Innovation Policy

Synergies and Complementarities with EU Research & Innovation Policy Synergies and Complementarities with EU Research & Innovation Policy Information Day - EIT 2014 Bernard Mulligan Petra Leroy Cadova Peter Wintlev-Jensen European Commission Budapest, 14 March 2014 Why

More information

Before I talk through the strategy itself, I want to tell you more about why

Before I talk through the strategy itself, I want to tell you more about why This presentation was given by Dr Annette Bramley, the Healthcare Technologies Theme leader. She thanked Professor Nelson and Professor Taylor for their presentations, and thanked everyone at the meeting

More information

Richard Anderson David Lubinski Kate Wilson

Richard Anderson David Lubinski Kate Wilson Richard Anderson David Lubinski Kate Wilson Planned talk Digital StudyHall evaluation study Distance learning project with University of Namibia and I-Tech Today s talk What I m doing on my sabbatical

More information

EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA

EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA Pan-Canadian Vision and Strategy for Health Services and Policy Research 2014 2019 EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA Partners involved Alberta Cancer

More information

The Industrial Strategy Challenge Fund

The Industrial Strategy Challenge Fund The Industrial Strategy Challenge Fund Mike Biddle Programme Director Industrial Strategy Challenge Fund @Mike_Biddle Harwell - 28 th November 2017 (v4) [Official] Overview 1. Industrial Strategy & the

More information

THE ACCESS AND DELIVERY PARTNERSHIP

THE ACCESS AND DELIVERY PARTNERSHIP THE ACCESS AND DELIVERY PARTNERSHIP Empowered lives. Resilient nations. New Health Technologies for TB, Malaria and NTDs The Access and Delivery Partnership a Tuberculosis (TB), malaria and neglected tropical

More information

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework for EU Research and Innovation Funding Position of the European Brain Council (EBC) Introduction The European Brain

More information

Draft global strategy on public health, innovation and intellectual property

Draft global strategy on public health, innovation and intellectual property IGWG: Outcome document at 14.00 hours, Saturday 3 May 2008 Draft global strategy on public health, innovation and intellectual property The context 1. In resolution WHA59.24 the Health Assembly recognized

More information

Impact Case Study Template. Guidance Document

Impact Case Study Template. Guidance Document Guidance Document I. Introduction The College of Arts, Celtic Studies and Social Sciences (CACSSS) at UCC has an excellent record in fostering and sustaining high quality research at the forefront of international

More information

Supporting Innovation through Regulation and Science

Supporting Innovation through Regulation and Science Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers

More information

The UNISDR Global Science & Technology Advisory Group for the implementation of the Sendai Framework for Disaster Risk Reduction UNISDR

The UNISDR Global Science & Technology Advisory Group for the implementation of the Sendai Framework for Disaster Risk Reduction UNISDR The UNISDR Global Science & Technology Advisory Group for the implementation of the Sendai Framework for Disaster Risk Reduction 2015-2030 UNISDR 1. Background - Terms of Reference - February 2018 The

More information

Draft executive summaries to target groups on industrial energy efficiency and material substitution in carbonintensive

Draft executive summaries to target groups on industrial energy efficiency and material substitution in carbonintensive Technology Executive Committee 29 August 2017 Fifteenth meeting Bonn, Germany, 12 15 September 2017 Draft executive summaries to target groups on industrial energy efficiency and material substitution

More information

2. Evidence themes and their importance along the development path

2. Evidence themes and their importance along the development path 1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development

More information

Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities

Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities Aleksandra Torbica, Carlo Federici, Rosanna Tarricone Centre for Research on Health and

More information

Health & Social Care Industrial Innovation

Health & Social Care Industrial Innovation Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging

More information

Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization

Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Research Note: Key findings

More information

COMMISSION STAFF WORKING PAPER EXECUTIVE SUMMARY OF THE IMPACT ASSESSMENT. Accompanying the

COMMISSION STAFF WORKING PAPER EXECUTIVE SUMMARY OF THE IMPACT ASSESSMENT. Accompanying the EUROPEAN COMMISSION Brussels, 30.11.2011 SEC(2011) 1428 final Volume 1 COMMISSION STAFF WORKING PAPER EXECUTIVE SUMMARY OF THE IMPACT ASSESSMENT Accompanying the Communication from the Commission 'Horizon

More information

The International Pharmacopoeia Overview

The International Pharmacopoeia Overview The International Pharmacopoeia Overview Prepared by Caroline Mendy Technical Officer - Quality Assurance and Safety: Medicines The International Pharmacopoeia P Content & Scope WHO Expert Committee on

More information

Framework Programme 7

Framework Programme 7 Framework Programme 7 1 Joining the EU programmes as a Belarusian 1. Introduction to the Framework Programme 7 2. Focus on evaluation issues + exercise 3. Strategies for Belarusian organisations + exercise

More information

A Science & Innovation Audit for the West Midlands

A Science & Innovation Audit for the West Midlands A Science & Innovation Audit for the West Midlands June 2017 Summary Report Key Findings and Moving Forward 1. Key findings and moving forward 1.1 As the single largest functional economic area in England

More information

December Eucomed HTA Position Paper UK support from ABHI

December Eucomed HTA Position Paper UK support from ABHI December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing

More information

STATUS REPORT For research on diseases of poverty. From the People of Japan. New Health Technologies for TB, Malaria and NTDs

STATUS REPORT For research on diseases of poverty. From the People of Japan. New Health Technologies for TB, Malaria and NTDs New Health Technologies for TB, Malaria and NTDs STATUS REPORT 2017 From the People of Japan For research on diseases of poverty UNICEF UNDP World Bank WHO The ADP partners The United Nations Development

More information

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry

More information

Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif

Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif Connect and Catalyse Medicines and Healthcare the Global perspective (+10 years) Zahid Latif % GDP spent on health OECD countries spent nearly $3.5trn in 2005 ($4.6 trillion in 2008) on healthcare services

More information

Higher Education Contribution to Health Science Innovation

Higher Education Contribution to Health Science Innovation Scottish University of the Year 2017 Higher Education Contribution to Health Science Innovation Professor Sir Pete Downes Principal, University of Dundee Lead Member for Health, Universities Scotland 28

More information

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei A Brief Introduction to the Regulatory Environment of Medical Device Supervision CFDA Department of Legal Affairs Liu Pei Development Trend of Medical Device Industry Development Opportunities of Medical

More information

JOB DESCRIPTION. Department: Technical Length of contract: 3 years renewable. Reporting to: Chief of Party Direct reports: Numbers to be confirmed

JOB DESCRIPTION. Department: Technical Length of contract: 3 years renewable. Reporting to: Chief of Party Direct reports: Numbers to be confirmed JOB DESCRIPTION Job title: Technical Director and Malaria Specialist Location: Luanda Angola Department: Technical Length of contract: 3 years renewable Role type: Global Grade: 10 Travel involved: Frequent

More information

EVCA Strategic Priorities

EVCA Strategic Priorities EVCA Strategic Priorities EVCA Strategic Priorities The following document identifies the strategic priorities for the European Private Equity and Venture Capital Association (EVCA) over the next three

More information

demonstrator approach real market conditions would be useful to provide a unified partner search instrument for the CIP programme

demonstrator approach real market conditions  would be useful to provide a unified partner search instrument for the CIP programme Contribution by the Ministry of Industry and Trade of the Czech Republic to the public consultations on a successor programme to the Competitiveness and Innovation Framework Programme (CIP) 2007-2013 Given

More information

Health Innovation Manchester

Health Innovation Manchester Health Innovation Manchester Accelerating innovation Discover Develop Deploy Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing

More information

II. The mandates, activities and outputs of the Technology Executive Committee

II. The mandates, activities and outputs of the Technology Executive Committee TEC/2018/16/13 Technology Executive Committee 27 February 2018 Sixteenth meeting Bonn, Germany, 13 16 March 2018 Monitoring and evaluation of the impacts of the implementation of the mandates of the Technology

More information

Security and Risk Assessment in GDPR: from policy to implementation

Security and Risk Assessment in GDPR: from policy to implementation Global Data Privacy Security and Risk Assessment in GDPR: from policy to implementation Enisa Workshop Roma - February 8, 2018 Nicola Orlandi Head of Data Privacy Pharma Nicola Orlandi Nicola Orlandi is

More information

Priorities for medical research in the UK

Priorities for medical research in the UK Priorities for medical research in the UK Sir Leszek Borysiewicz Medical Research Council The Foundation for Science and Technology, 20 May 2009 MRC mission Encourage and support high-quality research

More information

Commission proposal for Horizon Europe. #HorizonEU THE NEXT EU RESEARCH & INNOVATION PROGRAMME ( )

Commission proposal for Horizon Europe. #HorizonEU THE NEXT EU RESEARCH & INNOVATION PROGRAMME ( ) Commission proposal for Horizon Europe THE NEXT EU RESEARCH & INNOVATION PROGRAMME (2021 2027) #HorizonEU Jürgen Tiedje SPIRE PPP Brokerage Event 14 June 2018 Research and Innovation Horizon Europe is

More information

The efoodchain Action Workshop

The efoodchain Action Workshop The efoodchain Action Workshop copa*cogeca Brussels 10/9/2013 Dana Eleftheriadou Policy officer DG Enterprise and Industry KETs and Digital Economy Why ICT matters ICT is key enabler of competitiveness

More information

Initiatives to accelerate the deployment of Industry 4.0

Initiatives to accelerate the deployment of Industry 4.0 Initiatives to accelerate the deployment of Industry 4.0 Dr. Pierre Padilla, IDEA Consult ERRIN ADMA Working Group Tuesday, 20 June 2017 Brussels With the Support of Agenda 1. The Vanguard Initiative 2.

More information

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

25 th Workshop of the EURORDIS Round Table of Companies (ERTC) 25 th Workshop of the EURORDIS Round Table of Companies (ERTC) Healthcare Companies & European Reference Networks: Expectations & Potential for Collaboration Introduction Tuesday 26 September, 2017 (09:00

More information

Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value

Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value CADTH 2018 2021 STRATEGIC PLAN Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value Health care costs an estimated $242 billion annually

More information

IMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters!

IMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters! IMI Revolutionising Europe s Pharmaceutical Industry IMI Matters! Session in the Framework of the Event Joint Technology Initiatives Innovation in Action 4 6 October 2011 European Parliament Brussels Programme

More information

IP management in R&D for Neglected Tropical Diseases

IP management in R&D for Neglected Tropical Diseases IP management in R&D for Neglected Tropical Diseases Jean-Pierre Paccaud, PhD, DNDi, Director Business Development IP management in the Life Science Symposium, Dec 15 th, 2008, WIPO Only 21 New Drugs Developed

More information

Enhancing and focusing EU international cooperation in research and innovation: A strategic approach. Policy Research and Innovation

Enhancing and focusing EU international cooperation in research and innovation: A strategic approach. Policy Research and Innovation Enhancing and focusing EU international cooperation in research and innovation: A strategic approach A Rapidly Changing Context From a triad to a multipolar world STI increasingly internationally interconnected

More information

Innovation for Defence Excellence and Security (IDEaS)

Innovation for Defence Excellence and Security (IDEaS) ASSISTANT DEPUTY MINISTER (SCIENCE AND TECHNOLOGY) Innovation for Defence Excellence and Security (IDEaS) Department of National Defence November 2017 Innovative technology, knowledge, and problem solving

More information

WHO/PRP/11.1 ENGLISH ONLY MEDIUM-TERM STRATEGIC PLAN INTERIM ASSESSMENT

WHO/PRP/11.1 ENGLISH ONLY MEDIUM-TERM STRATEGIC PLAN INTERIM ASSESSMENT WHO/PRP/11.1 ENGLISH ONLY MEDIUM-TERM STRATEGIC PLAN 2008 2013 INTERIM ASSESSMENT The colour coding used in this document for all graphs and tables (except for the graphs on the priorities using a relative

More information

In-Country Shared Value Creation The Case of Ghana

In-Country Shared Value Creation The Case of Ghana In-Country Shared Value Creation The Case of Ghana 6 th Plenary Session, OECD Policy Dialogue on Natural Resource-Based Development Paris, 22 23 June 2016 Isabelle RAMDOO African Minerals Development Centre

More information

ASEAN Regulatory Harmonisation and Approval Process

ASEAN Regulatory Harmonisation and Approval Process ASEAN Regulatory Harmonisation and Approval Process Selvaraja Seerangam National Pharmaceutical Control Bureau Ministry of Health Malaysia Open Forum on Key Issues on TB Drug Development- 18-19 August

More information

Initial draft of the technology framework. Contents. Informal document by the Chair

Initial draft of the technology framework. Contents. Informal document by the Chair Subsidiary Body for Scientific and Technological Advice Forty-eighth session Bonn, 30 April to 10 May 2018 15 March 2018 Initial draft of the technology framework Informal document by the Chair Contents

More information

Economic and Social Council

Economic and Social Council United Nations Economic and Social Council Distr.: General 11 February 2013 Original: English Economic Commission for Europe Sixty-fifth session Geneva, 9 11 April 2013 Item 3 of the provisional agenda

More information

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow The context Demographics On-going financial constraints

More information

ENCePP Work Plan

ENCePP Work Plan EMA/150117/2014 ENCePP Secretariat European Network of Centres for Pharmacoepidemiology and Pharmacovigilance European Network of Centres for Pharmacoepidemiology and Pharmacovigilance Adopted by the ENCePP

More information

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry

More information

Evidence for Effectiveness

Evidence for Effectiveness Evidence for Effectiveness Developing a standards framework for digital health innovations Digitally empowering people to manage their health and care October 2018 The issue NHS England programmes Apps

More information

EU Cooperation on Health Technology Assessment

EU Cooperation on Health Technology Assessment Strategy for EU Cooperation on Health Technology Assessment Strategy for EU cooperation on Health Technology Assessment (HTA) The HTA Network is a voluntary network, set up by Directive2011/24 (article

More information

Cancer. Overview. average 2 It is also important to remember that this assessment is relative: a CCG might make improvements on all

Cancer. Overview. average 2 It is also important to remember that this assessment is relative: a CCG might make improvements on all Cancer Overview 1. The CCG Improvement and Assessment Framework provides information to health care organisations, professionals and patients about how their local NHS services are performing and is used

More information

Focus on Innovation. Historical Perspective on Forest Sector Science and Technology Alignment: The Foundation for Forest Sector Transformation

Focus on Innovation. Historical Perspective on Forest Sector Science and Technology Alignment: The Foundation for Forest Sector Transformation CANADIAN FOREST SERVICE Focus on Innovation INFORMATION NOTE 2 Historical Perspective on Forest Sector Science and Technology Alignment: The Foundation for Forest Sector Transformation Introduction The

More information

THEFUTURERAILWAY THE INDUSTRY S RAIL TECHNICAL STRATEGY 2012 INNOVATION

THEFUTURERAILWAY THE INDUSTRY S RAIL TECHNICAL STRATEGY 2012 INNOVATION 73 INNOVATION 74 VISION A dynamic industry that innovates to evolve, grow and attract the best entrepreneurial talent OBJECTIVES Innovation makes a significant and continuing contribution to rail business

More information

WSIS+10 REVIEW: NON-PAPER 1

WSIS+10 REVIEW: NON-PAPER 1 WSIS+10 REVIEW: NON-PAPER 1 Preamble 1. We reaffirm the vision of a people-centred, inclusive and development-oriented Information Society defined by the World Summit on the Information Society (WSIS)

More information

The work under the Environment under Review subprogramme focuses on strengthening the interface between science, policy and governance by bridging

The work under the Environment under Review subprogramme focuses on strengthening the interface between science, policy and governance by bridging The work under the Environment under Review subprogramme focuses on strengthening the interface between science, policy and governance by bridging the gap between the producers and users of environmental

More information

Software as a Medical Device (SaMD)

Software as a Medical Device (SaMD) Software as a Medical Device () Working Group Status Application of Clinical Evaluation Working Group Chair: Bakul Patel Center for Devices and Radiological Health US Food and Drug Administration NWIE

More information

Biomedical Innovation Has Science Overtaken the System?

Biomedical Innovation Has Science Overtaken the System? Adaptive Pathways for Transformative Medicinal Products. A New Paradigm with the Enhanced Application of Real-World Evidence? ISPOR 20 th Annual European Congress, Glasgow, Scotland Issue Panel 21, Wednesday,

More information

Artemisinin Scenario Analysis Summary of findings. October, 2009

Artemisinin Scenario Analysis Summary of findings. October, 2009 Artemisinin Scenario Analysis Summary of findings October, 2009 Acknowledgements We would like to thank the following individuals who provided their input to this analysis: CHAI Justin Cohen, Sanjay Patel

More information

The Role of the Communities of Interest (COIs) March 25, Dr. John Stubstad Director, Space & Sensor Systems, OASD (Research & Engineering)

The Role of the Communities of Interest (COIs) March 25, Dr. John Stubstad Director, Space & Sensor Systems, OASD (Research & Engineering) The Role of the Communities of Interest (COIs) March 25, 2015 Dr. John Stubstad Director, Space & Sensor Systems, OASD (Research & Engineering) Communities of Interest (COIs) Role in Reliance 21 Communities

More information

Quality assurance in the supply chain for pharmaceuticals from the WHO perspective

Quality assurance in the supply chain for pharmaceuticals from the WHO perspective 1 Quality assurance in the supply chain for pharmaceuticals from the WHO perspective Dr Sabine Kopp Quality Assurance and Safety: Medicines Medicines Policy and Standards World Health Organization Presentation

More information

An Essential Health and Biomedical R&D Treaty

An Essential Health and Biomedical R&D Treaty An Essential Health and Biomedical R&D Treaty Submission by Health Action International Global, Initiative for Health & Equity in Society, Knowledge Ecology International, Médecins Sans Frontières, Third

More information

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation Doing, supporting and using public health research The Public Health England strategy for research, development and innovation Draft - for consultation only About Public Health England Public Health England

More information

Implementing Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property in the Eastern Mediterranean Region

Implementing Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property in the Eastern Mediterranean Region Implementing Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property in the Eastern Mediterranean Region 1 Table of Contents LIST OF ACRONYMS AND ABBREVIATIONS -----------------------------------------------------------------------------------

More information

Towards malaria elimination: ADB-supported work at Myanmar FDA

Towards malaria elimination: ADB-supported work at Myanmar FDA Towards malaria elimination: ADB-supported work at Myanmar FDA Valerio Reggi 25 January 2018 Disclaimer: The views expressed in this paper/presentation are the views of the author and do not necessarily

More information

PROGRAM BRIEF: PSI/MYANMAR. Improving Malaria Case Management in the Private Sector: Artemisinin Monotherapy Replacement (AMTR) Project. psi.

PROGRAM BRIEF: PSI/MYANMAR. Improving Malaria Case Management in the Private Sector: Artemisinin Monotherapy Replacement (AMTR) Project. psi. PROGRAM BRIEF: PSI/MYANMAR Improving Malaria Case Management in the Private Sector: Artemisinin Monotherapy Replacement (AMTR) Project psi.org 1 Artemisinin Monotherapy Replacement Project 2012-2015 AMTR

More information

Disruptive SBC strategies for the future of Africa

Disruptive SBC strategies for the future of Africa Disruptive SBC strategies for the future of Africa 1 About Social & Behaviour Change All human interactions - be they social, economic or political - are shaped by behaviour. These interactions are the

More information

Technology and Innovation in the NHS Scottish Health Innovations Ltd

Technology and Innovation in the NHS Scottish Health Innovations Ltd Technology and Innovation in the NHS Scottish Health Innovations Ltd Introduction Scottish Health Innovations Ltd (SHIL) has, since 2002, worked in partnership with NHS Scotland to identify, protect, develop

More information

Abt Associates Inc Montgomery Avenue, Suite 800 North Bethesda, Maryland T: F:

Abt Associates Inc Montgomery Avenue, Suite 800 North Bethesda, Maryland T: F: RAPID ASSESSMENT OF THE TECHNICAL SUPPORT NETWORK PROVIDED BY THE WORLD HEALTH ORGANIZATION TO THE REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME IN INDIA August 2016 This publication was produced for

More information

ARTEMIS The Embedded Systems European Technology Platform

ARTEMIS The Embedded Systems European Technology Platform ARTEMIS The Embedded Systems European Technology Platform Technology Platforms : the concept Conditions A recipe for success Industry in the Lead Flexibility Transparency and clear rules of participation

More information

The impact of rapid technological change on sustainable development

The impact of rapid technological change on sustainable development 15-17 January 2019, Vienna The impact of rapid technological change on sustainable development Shamika N. Sirimanne Director, Division on Technology and Logistics UNCTAD 2018-2019 CSTD Intersessional Panel

More information

Extract of Advance copy of the Report of the International Conference on Chemicals Management on the work of its second session

Extract of Advance copy of the Report of the International Conference on Chemicals Management on the work of its second session Extract of Advance copy of the Report of the International Conference on Chemicals Management on the work of its second session Resolution II/4 on Emerging policy issues A Introduction Recognizing the

More information

Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use

Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use Rosmin Esmail MSc, CHE Director, Knowledge Translation Research, Analytics and Innovation Portfolio Alberta

More information

13-17 OCTOBER 2008 AU/MIN/ CAMRMRD /4(I) ADDIS ABABA DECLARATION ON DEVELOPMENT AND MANAGEMENT OF AFRICA S MINERAL RESOURCES.

13-17 OCTOBER 2008 AU/MIN/ CAMRMRD /4(I) ADDIS ABABA DECLARATION ON DEVELOPMENT AND MANAGEMENT OF AFRICA S MINERAL RESOURCES. AFRICAN UNION UNION AFRICAINE UNIÃO AFRICANA Addis Ababa, ETHIOPIA P. O. Box 3243 Telephone 517 700 Fax: +251-1-517844 AU CONFERENCE OF MINISTERS RESPONSIBLE 1 ST ORDINARY SESSION 13-17 OCTOBER 2008 AU/MIN/

More information

Higher Education for Science, Technology and Innovation. Accelerating Africa s Aspirations. Communique. Kigali, Rwanda.

Higher Education for Science, Technology and Innovation. Accelerating Africa s Aspirations. Communique. Kigali, Rwanda. Higher Education for Science, Technology and Innovation Accelerating Africa s Aspirations Communique Kigali, Rwanda March 13, 2014 We, the Governments here represented Ethiopia, Mozambique, Rwanda, Senegal,

More information

Horizon 2020 and Photonics

Horizon 2020 and Photonics Brussels, 13 December 2013 Horizon 2020 and Photonics Thomas Skordas Head of the Photonics Unit, DG CONNECT European Commission Thomas.Skordas@ec.europa.eu Horizon 2020 Horizon 2020 Budget: 78.6 B (in

More information